bpc-157 safety evidence Peptide Most FDA advisers say peptides

In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals

I had coaches when I was doing martial arts

You must obtain a prescription from a doctor whose scope of practice allows them to prescribe drugs (MD, DO, ND/NMD) or a nurse with prescription rights who is under the direct supervision of a physician

When administered properly under medical supervision, serious adverse effects are rare